Toggle navigation
Home
Search
Services
Blog
Contact
About
In situ single cell imaging
Gao, Feng
Dotquant, LLC, Shoreline, WA, United States
Search 38 grants from Feng Gao
Search grants from Dotquant, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Liver Kinase B1, a genetic risk factor for multiple sclerosis
Multiscale simulations of transport in DNA and DNA-carbon nanotube systems
Sampler for viable ariborne bacteria, fungi and virus.
Novel Antifungal Drug Targets in Cryptococcus Neoformans
Effects of Dsrna Adenosine Deaminase (DRADA) on Antisense RNA Strategy
Recently added grants:
DOTA-based pre-targeting of alpha emitters
Role of HIV in acceleration of HPV malignancy
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
Role of the gut microbiome in modulating the efficacy of checkpoint blockade therapy
Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
4R44CA239939-02
Application #
10062602
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Canaria, Christie A
Project Start
2019-12-11
Project End
2021-11-30
Budget Start
2019-12-11
Budget End
2020-11-30
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Dotquant, LLC
Department
Type
DUNS #
079125762
City
Shoreline
State
WA
Country
United States
Zip Code
98155
Related projects
NIH 2021
R44 CA
In situ single cell imaging
Gao, Feng / Dotquant, LLC
NIH 2020
R44 CA
In situ single cell imaging
Gao, Feng / Dotquant, LLC
NIH 2019
R44 CA
In situ single cell imaging
Gao, Feng / Dotquant, LLC
Comments
Be the first to comment on this grant